Launched in 2011, FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.

The FEBS-IUBMB-ENABLE Conference is a joint initiative of FEBS, IUBMB, and several leading European biomedical research institutes (the ENABLE partners), building on a successful project originally funded by the EU Horizon 2020 Research and Innovation Programme (2017–2020). These interdisciplinary, international, three-day events are organized by and for young researchers in the molecular life sciences and attract up to 300 participants from around the world. Each conference features a scientific symposium, a career day, and outreach activities. ENABLE (the European Academy for Biomedical Science) was launched in 2017 through the collaboration of four renowned European institutes: the Institute for Research in Biomedicine (IRB Barcelona, Spain), the Novo Nordisk Foundation Center for Protein Research (NNF-CPR, Denmark), the Radboud Institute for Molecular Life Sciences at Radboudumc (Netherlands), and the European School of Molecular Medicine (SEMM, Italy). These core institutions hosted the first four conferences from 2017 to 2021. In 2022, FEBS and IUBMB joined forces with the ENABLE founders to relaunch the initiative as FEBS-IUBMB-ENABLE, expanding its reach and impact. In this new cycle, institutions can apply to become associated centres and host one of the events. 

Currently Honorary Professor of the Free University of Brussels (ULB) Medical Faculty, Belgium. Besides 35 years of basic and translational medical research, I also spent 4 years in industry as head of the Molecular Biology lab at Baxter Healthcare research facility in Belgium. I spent 10 years supervising and managing Biochemistry wet labs and thereafter 15 years teaching Molecular Biology to medical, biomedical and veterinary students (BA2) but also to Biomedical Civil Engineers (MA1).I also supervised or co-supervised PhDs, MD clinician-researchers and 40 Biomedical and Medical Master's theses.  I am currently President of the Belgian Society for Biochemistry and Molecular Biology. I have been with FEBS since 2003 as a member of the FEBS Education Working Group and then Committee, and after 2012 actively contributing to FEBS education activities such as presenting talks and workshops on various topics and YSF. LBPN Lab Web Pages Publications-Scholar

I obtained my PhD in plant molecular biology from the University of Nottingham and have spent the past 30 years in science publishing. I've worked for various journals, including Nature and Trends in Biochemical Sciences, and also edited many books. I was the Executive Editor of FEBS Open Bio from its launch in 2011 until 2019.

I am an Associate Professor at the Department of Biochemistry and Clinical Analysis at the Faculty of Pharmacy, University of Sarajevo. My research interest in general is the area of genetics of type 2 diabetes, obesity and metabolic syndrome, pharmacogenetics of diabetes, association of inflammatory biomarkers and free fatty acids with diabetes, obesity and metabolic syndrome.

The Society was founded by Professor Maurice Nicloux on March 14, 1914 at the College de France in Paris. The Society gathers people with expertise in Biochemistry, Molecular biology, Structural Biology, Integrative Biology.

DNA replication, DNA repeats, Replication slippage, DNA Repair, Bacterial Genetics, Genetic Instability

I became an MD in 1972, then decided to do research in biomedical sciences and received my PhD in immunology in 1978. I spent 3 years as a postdoctoral fellow at NIH, USA, then started a university carrier in Debrecen where became professor of biochemistry and molecular biology in 1988 at the Faculty of Medicine, then chairman of this department between 1993 and 2013. My research group has focused on molecular mechanisms in cell death, structure and function of transglutaminases with clinical implications, inflammation, differentiation and functions of white and brown adipocytes. I was visiting professor at the University of Texas and the University of Rome, coordinated major European projects of COST, ESF and EU-Frame Work programs. I was rector (1999-2001, 2007-2010) and president of the Medical and Health Science Center (2001-2007) of the University of Debrecen. Elected to chair the Hungarian Accreditation Committee for Higher Education (2004-2007), the Hungarian Biochemical Society (2005-2015) and became a member of the Hungarian Academy of Sciences in 1998 where chaired the Science and Ethics Committee and currently chair the Biology Section of the Academy. In 2010 I was elected to be the member of the Committee on Science and Ethics of All European Academies (ALLEA) and participated in the drafting group of the recently published new European Code of Conduct for Research Integrity. . Since 2012 I chair the Publications Committee of the Federation of European Biochemical Societies and I am member of FEBS Executive Committee.